Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 7, 1998, Pages 1831-1836

  Schmuck, Gabriele ^a   Schürmann, Anja ^a   Schlüter, Gerhard ^a  

^a BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

7 (1 AMINOMETHYL 2 OXA 7 AZABICYCLO[3.3.0]OCT 7 YL) 1 CYCLOPROPYL 6,8 DIFLUORO 1,4 DIHYDRO 4 OXO 3 QUINOLINECARBOXYLIC ACID; BAY 157828; CIPROFLOXACIN; CLINAFLOXACIN; ENOXACIN; FLEROXACIN; LOMEFLOXACIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALIDIXIC ACID; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOSUFLOXACIN; TROVAFLOXACIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; EVOKED BRAIN STEM RESPONSE; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0344015783     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.7.1831     Document Type: Article

References (40)

1. Akahane, K., M. Sekiguchi, T. Une, and Y. Osada. 1989. Structure-eleptogenicity relationship of quinolones with special reference to their interaction with γ-aminobutyric acid receptor sites. Antimicrob. Agents Chemother. 33: 1704-1708.
2. A receptors in dissociated hippocampal cells of the rat. J. Neurophysiol. 66:497-504.
3. Alger, B. E., S. S. Dhanjal, R. Dingledine, J. Garthwaite, G. Henderson, G. King, P. Lipton, A. North, P. A. Schwarzkroin, T. A. Sears, M. Segal, T. S. Whittingham, and J. Williams. 1984. Brain slice methods, p. 155-193. In R. Dingledine (ed.), Brain slices. Plenum Press, New York, N.Y.
4. Alger, B. E. 1991. Gating of GABAergic inhibition in hippocampal pyramidal cells. Ann. N. Y. Acad. Sci. 627:249-263.
5. Christ, W. 1990. Central nervous system toxicity of quinolones: human and animal findings. J. Antimicrob. Chemother. 26(Suppl. B):219-225.
6. Dalhoff, A. 1989. A review of quinolone tissue pharmacokinetics, p. 277-302. In P. B. Fernandes (ed.), Quinolones: proceedings of international telesymposium May 1989. J. R. Prous Science Publisher, S. A. Philadelphia, Pa.
7. Davies, B. J., and P. V. Maesen. 1989. Drug interaction with quinolones. Rev. Infect. Dis. 11(Suppl. 5):S1083-S1090.
8. De Sarro, A., D. Ammendola, and G. DeSarro. 1994. Effects of some quinolones on imipenem-induced seizures in DBA/2 mice. Gen. Pharmacol. 25: 369-379.
9. Dimpfel, W., M. Spüler, A. Dalhoff, W. Hofmann, and G. Schlüter. 1991. Hippocampal activity in the presence of quinolones and fenbufen in vitro. Antimicrob. Agents Chemother. 35:1142-1146.
10. Dimpfel, W., A. Dalhoff, and E. von Keutz. 1996. In vitro modulation of hippocampal pyramidal cell response by quinolones: effects of HA 966 and γ-hydroxybutyric acid. Antimicrob. Agents Chemother. 40:2573-2576.
11. Dingledine, R. 1986. NMDA receptors: what do they do? Trends Neurosci. 9:47-49.
12. Dodd, P. R., L. P. Davies, W. E. J. Watson, B. Nielsen, J. A. Deyer, L. S. Wong, and G. A. R. Johnston. 1989. Neurochemical studies on quinolone antibiotics: effects on glutamate, GABA and adenosine systems in mammalian CNS. Pharmacol. Toxicol. 64:404-411.
13. Gilbert, M. E., and L. J. Burdette. 1995. Hippocampal field potentials: a model system to characterize neurotoxicity, p. 183-204. In L. W. Chang and W. Slikker (ed.), Neurotoxicology; approaches and methods. Academic Press, San Diego, Calif.
14. Goldman, J., and L. Côté. 1991. Aging of the brain: dementia of the Alzheimer's type, p. 974-983. In E. R. Kandel, J. H. Schwartz, and T. M. Jessell (ed.), Principles of neural science. Prentice-Hall International, Inc., Englewood Cliffs, N.J.
15. Halliwell, R. F., J. J. Labert, and P. G. Davey. 1989. Actions of quinolones and non-steroidal antiinflammatory drugs on γ-aminobutyric acid currents of rat dorsal root ganglion neurons. Rev. Infect. Dis. 11(Suppl. 5):S1398-S1399.
16. Halliwell, R. F., P. G. Davey, and J. J. Lambert. 1991. The effect of quinolones and NSAIDs upon GABA evoked currents recorded from dorsal root ganglia neurons. J. Antimicrob. Chemother. 27:209-218.
17. Halliwell, R. F. 1992. Electrophysiological study of a novel antagonist interaction between certain 4-quinolones and the GABA receptor. Ph.D. thesis. University of Dundee, Dundee, United Kingdom.
18. A receptors by 4-quinolones. J. Antimicrob. Chemother. 31:457-462.
19. Hara, Y., T. Suzuki, A. Ally, and S. Murayama. 1992. Effects of MK-801 on the convulsions induced by a combination of enoxacin with fenbufen. Jpn. J. Pharmacol. 58(Suppl. 1):179.
20. Hori, S., and J. Shimada. 1993. Effects of quinolones on the central nervous system, p. 513-518. In D. C. Hooper and J. S. Wolfson (ed.), Quinolone antimicrobial agents, 2nd ed. American Society for Microbiology, Washington, D.C.
21. Huettner, J. E. 1991. Competitive antagonism of glycine at the n-methyl-d-aspardate (NMDA) receptor. Biochem. Pharmacol. 41:9-16.
22. Imanishi, T., K. Akahane, and N. Akaike. 1995. Attenuated inhibition by levofloxacin, 1-isomer of ofloxacin, on GABA response in dissociated rat hippocampal neurons. Neurosci. Lett. 193:81-84.
23. Kitzes-Cohen, R. 1989. CNS pharmacokinetics of quinolones. Quinolones in CNS infections, p. 313-326. In P. B. Fernandes (ed.), Quinolones: proceedings of international telesymposium May 1989. J. R. Prous Science Publisher, S.A. Philadelphia, Pa.
24. Lecomte, S., C. Coupry, M. T. Chenon, and M. Mureau. 1993. Affinity of sparfloxacin and 4 other fluoroquinolones for magnesium and effects on antibacterial activity. Drugs 45(Suppl.):148-149.
25. Nix, D. E. 1993. Drug-drug interactions with fluoroquinolone antimicrobial agents, p. 245-258. In D. C. Hooper and J. S. Wolfson (ed.), Quinolone antimicrobial agents. 2nd ed. American Society for Microbiology, Washington, D.C.
26. Nowak, L., P. Bregestovski, P. Ascher, A. Herbert, and A. Prochiantz. 1989. Magnesium gates glutamate-activated channels in mouse central neurons. Nature 307:462-465.
27. Nozaki, M., N. Takeda, K. Tanaka, and K. Tsurumi. 1989. GABAergic mechanism on convulsions induced by combination with new quinolones and NSAID; true or not. In Proceedings of 16th International Congress of Chemotherapy in Jerusalem, June 1989.
28. Nozaki, M., N. Takeda, M. Tanba, S. Turumi, and H. Fujimura. 1990. Mechanisms of convulsions induced by simultaneous administration of new-quinolones and anti-inflammatory agents. Folia Pharmacol. Jpn. 95:33. (In Japanese.)
29. Peeters, B. W. M. M., and P. M. L. Vanderheyden. 1992. In vitro and in vivo characterization of the NMDA receptor-linked strychnine-insensitive glycine site. Epilepsy Res. 12:157-162.
30. Percival, A. 1991. Impact of chemical structure on quinolone potency, spectrum and side effects. J. Antimicrob. Chemother. 28(Suppl. C):1-8.
31. Raasch, W., H. Grobecker, and F. Kees. 1992. Influence of ciprofloxacin on brain metabolism of biogenic amines in the rat. Pharmacol. Lett. 2:153-156.
32. Shalaby, I., B. Chenard, and M. Prochniak. 1989. Glycine reverses 7-Cl kynurenate blockade of glutamate neurotoxicity in cell culture. Eur. J. Pharmacol. 160:309-311.
33. Shirasaki, T., N. Harata, T. Nakaye, and N. Akaike. 1991. Interaction of various non-steroidal antiinflammatories and quinolone antimicrobials on GABA response in rat dissociated hippocampal pyramidal neurons. Brain Res. 562:329-331.
34. Shirasaki, T., N. Harata, T. Nakaye, and N. Akaike. 1991. Quinolones do not interact with NMDA receptors in dissociated rat hippocampal neurons. Brain Res. 562:344-346.
35. Stahlmann, R., J. Vormann, T. Günther, C. Förster, U. Zippel, E. Lozo, R. Schwabe, K. Kociok, M. Shakibaei, and H.-J. Merker. 1997. Effects of quinolones, magnesium deficiency or zinc deficiency of joint cartilage in rats. Magnesium Bull. 19:7-22.
36. Tanaka, K., M. Nozaki, M. Tanba, and S. Turumi. 1991. Convulsion induced by new-quinolones and anti-inflammatory agents (III): neurotoxicity of new-quinolones. Folia Pharmacol. Jpn. 97:31. (In Japanese.)
37. Tsuji, A., H. Sato, Y. Kume, I. Tamai, E. Okezaki, O. Nagata, and H. Kato. 1988. Inhibitory effects on quinolone antibacterial agents on γ-aminohutyric acid binding to receptor sites in the brain membranes. Antimicrob. Agents Chemother. 32:190-194.
38. Wallis, R. A., K. L. Panizzon, and J. P. Nolan. 1994. Giycine-induccd CA1 excitotoxicity in the hippocampal slice. Brain Res. 664:115-125.
39. Williams, P. D., and D. R. Helton. 1991. The proconvulsive activity of quinolone antibiotics in an animal model. Toxicol. Lett. 58:23-28.
40. Yamamoto, T., and McIlwain. 1966. Electrical activities in thin sections from the mammalian brain maintained in chemically defined media in vitro. J. Neurochem. 13:1333-1343.